A novel implanted cardiac device-based multisensor monitoring algorithm has proven predictive of heart failure (HF) decompensation, but the temporal risk of hospitalisation during state of alert has yet to be quantified.
To quantify the within-patient temporal risk of acute HF hospitalisation during multis...
L. Davodian, D. Davodian, F. Fussing et al.· European Heart Journal· 0 citations
Disturbances in the bone and mineral homeostasis are central drivers of cardiovascular disease in chronic kidney disease (CKD), contributing to vascular calcification and left ventricular hypertrophy. In DECODE-CKD, the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin induced significant left ventr...
K. Bartholdy, N. Johansen, D. Modin et al.· European Heart Journal· 0 citations
Metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with an increased risk of heart failure, particularly heart failure with preserved ejection fraction (HFpEF). The prevalence of HFpEF and related patient-reported functional limitations in MASLD patients with preserved left ventricular...
M. Ramadan, F. S. Davidovski, C. Espersen et al.· European Heart Journal· 0 citations